Lumendi

Focus: Lumendi is a surgical device company focused on endolumenal interventional platforms for gastroenterology, specifically targeting colon polyp removal and treatment. The company is early-stage with minimal public financial disclosure.

Gastroenterology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Lumendi

AI assessmentNot Hiring

No open roles listed right now. Follow Lumendi to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

4 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

DiLumen

Colon Polyp

N/A

Clinical Trials (1)

NCT03113578Evaluation of the DiLumen Device During Colonoscopy

N/A

Help build intelligence for Lumendi

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Join a focused medtech innovator with a defined product portfolio targeting a large gastroenterology market
Opportunity to shape early-stage commercial strategy in surgical devices with only 1 active sales role currently open
Exposure to multiple platform variations (DiLumen, Double Balloon) that could establish category leadership in endolumenal interventions

Watch Out For

Extremely limited hiring activity (only 1 open role) signals either plateau or pre-commercialization phase with uncertain scaling
No disclosed revenue, R&D spend, or financial data creates visibility risk around company runway and burn rate
Four pipeline programs all in exploratory phase (no formal FDA phases listed) with only 4 total trials suggests early development stage

Generated by Claude from Lumendi's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Double Balloon Endoluminal Platform

Colon Adenoma

N/A

Clinical Trials (1)

NCT03551379A Double Balloon Endoscopic Platform for ESD

N/A

Double balloon accessory device

Adenomatous Polyp of Colon

N/A

Clinical Trials (1)

NCT03942965Registry Evaluation of a Double Balloon Accessory Device

N/A

DiLumen C2 Endolumenal Interventional Platform

Polyps of Colon

N/A

Clinical Trials (1)

NCT04657601Prospective Study of a New Endolumenal Device Used During Endoscopic Polypectomy in the Colon

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2017

Portfolio: 4 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo